[{"address1": "101 Lindenwood Drive", "address2": "Suite 225", "city": "Malvern", "state": "PA", "zip": "19355", "country": "United States", "phone": "610 725 1500", "website": "https://www.galeratx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Galera Therapeutics, Inc., a biopharmaceutical company, focuses on the development of a portfolio of small molecule dismutase (SOD) mimetics to improve radiotherapy in cancer. The company's lead product is tilarginine that is in Phase 1/2 trial of a pan-inhibitor of nitric oxide synthase to treat patients with highly resistant forms of breast cancer, including metaplastic breast cancer (MpBC) and other refractory subsets of triple-negative breast cancer (TNBC). It develops avasopasem manganese, a small molecule dismutase mimetic for the treatment of radiotherapy induced severe oral mucositis in patients with head and neck cancer (HNC); for the treatment of radiotherapy-induced esophagitis in patients with lung cancer; and for patients with HNC undergoing standard-of-care radiotherapy that is in Phase 2a clinical trial. The company was incorporated in 2012 and is based in Malvern, Pennsylvania.", "fullTimeEmployees": 3, "companyOfficers": [{"maxAge": 1, "name": "Dr. J. Mel Sorensen M.D.", "age": 68, "title": "CEO, President & Chairman", "yearBorn": 1957, "fiscalYear": 2024, "totalPay": 633279, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Joel F. Sussman CMA, CPA", "age": 76, "title": "Chief Accounting Officer, Secretary & Treasurer", "yearBorn": 1949, "fiscalYear": 2024, "totalPay": 349440, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 9, "compensationRisk": 8, "shareHolderRightsRisk": 7, "overallRisk": 9, "governanceEpochDate": 1768176000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.022, "open": 0.0211, "dayLow": 0.0211, "dayHigh": 0.0211, "regularMarketPreviousClose": 0.022, "regularMarketOpen": 0.0211, "regularMarketDayLow": 0.0211, "regularMarketDayHigh": 0.0211, "payoutRatio": 0.0, "beta": 1.924, "forwardPE": -0.017741935, "volume": 2416, "regularMarketVolume": 2416, "averageVolume": 40201, "averageVolume10days": 6360, "averageDailyVolume10Day": 6360, "bid": 0.0212, "ask": 0.0244, "bidSize": 23000, "askSize": 10000, "marketCap": 1660172, "fiftyTwoWeekLow": 0.015, "fiftyTwoWeekHigh": 0.048, "allTimeHigh": 19.5, "allTimeLow": 0.015, "fiftyDayAverage": 0.02298, "twoHundredDayAverage": 0.023255, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 150752800, "profitMargins": 0.0, "floatShares": 44187757, "sharesOutstanding": 75462390, "sharesShort": 2123783, "sharesShortPriorMonth": 2657537, "sharesShortPreviousMonthDate": 1713139200, "dateShortInterest": 1715731200, "sharesPercentSharesOut": 0.039, "heldPercentInsiders": 0.32694998, "heldPercentInstitutions": 0.0999, "shortRatio": 1.16, "shortPercentOfFloat": 0.052800003, "impliedSharesOutstanding": 75462390, "bookValue": -1.977, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -8986000, "trailingEps": -0.1, "forwardEps": -1.24, "enterpriseToEbitda": -24.545, "52WeekChange": -0.51111114, "SandP52WeekChange": 0.16255379, "quoteType": "EQUITY", "currentPrice": 0.022, "recommendationKey": "none", "totalCash": 4473000, "totalCashPerShare": 0.059, "ebitda": -6142000, "totalDebt": 151048992, "quickRatio": 7.48, "currentRatio": 8.196, "returnOnAssets": -0.55357, "freeCashflow": -3434125, "operatingCashflow": -6790000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "GRTX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "earningsTimestampStart": 1755001800, "earningsTimestampEnd": 1755520200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.1, "epsForward": -1.24, "fiftyDayAverageChange": -0.000980001, "fiftyDayAverageChangePercent": -0.04264582, "twoHundredDayAverageChange": -0.001255, "twoHundredDayAverageChangePercent": -0.05396689, "priceToBook": -0.011127972, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "regularMarketChangePercent": 0.0, "regularMarketPrice": 0.022, "regularMarketTime": 1769720400, "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "exchange": "OQB", "messageBoardId": "finmb_225098093", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "hasPrePostMarketData": false, "firstTradeDateMilliseconds": 1573137000000, "regularMarketChange": 0.0, "regularMarketDayRange": "0.0211 - 0.0211", "fullExchangeName": "OTC Markets OTCQB", "averageDailyVolume3Month": 40201, "fiftyTwoWeekLowChange": 0.007, "fiftyTwoWeekLowChangePercent": 0.4666667, "fiftyTwoWeekRange": "0.015 - 0.048", "fiftyTwoWeekHighChange": -0.026, "fiftyTwoWeekHighChangePercent": -0.5416667, "fiftyTwoWeekChangePercent": -51.111115, "marketState": "CLOSED", "shortName": "Galera Therapeutics, Inc.", "longName": "Galera Therapeutics, Inc.", "corporateActions": [], "cryptoTradeable": false, "displayName": "Galera Therapeutics", "trailingPegRatio": null, "__fetch_time": "2026-01-31"}]